{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:16:30Z","timestamp":1768832190057,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003185","name":"Fraunhofer-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1007\/s12602-018-9437-4","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T04:39:32Z","timestamp":1530333572000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying"],"prefix":"10.1007","volume":"11","author":[{"given":"Elzaan","family":"Booysen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bezuidenhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton Du Preez","family":"van Staden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimiter","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly M.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon M. T.","family":"Dicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,30]]},"reference":[{"key":"9437_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nbt1006-1211","volume":"24","author":"V Wagner","year":"2006","unstructured":"Wagner V, Dullaart A, Bock A-K, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24:1211\u20131217","journal-title":"Nat Biotechnol"},{"key":"9437_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rb\/rbw033","volume":"3","author":"S Yao","year":"2016","unstructured":"Yao S, Liu H, Yu S, Li Y, Wang X, Wang L (2016) Drug-nanoencapsulated PLGA microspheres prepared by emulsion electrospray with controlled release behavior. Regen Biomater 3:309\u2013317","journal-title":"Regen Biomater"},{"key":"9437_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505\u2013522","journal-title":"J Control Release"},{"key":"9437_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijpharm.2004.01.033","volume":"275","author":"K Dillen","year":"2004","unstructured":"Dillen K, Vandervoort J, Van Den Mooter G, Verheyden L, Ludwig A (2004) Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 275:171\u2013187","journal-title":"Int J Pharm"},{"key":"9437_CR5","doi-asserted-by":"crossref","unstructured":"Salouti M, Ahangari A (2014) Nanoparticle based drug delivery systems for treatment of infectious diseases. In: Sezer AD (ed) Application of nanotechnology in drug delivery. InTech, pp 155\u2013192","DOI":"10.5772\/58423"},{"key":"9437_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.colsurfb.2012.10.021","volume":"103","author":"P Zakeri-milani","year":"2013","unstructured":"Zakeri-milani P, Loveymi BD, Jelvehgari M, Valizadeh H (2013) The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces 103:174\u2013181. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2012.10.021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"9437_CR7","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1021\/nn102324e","volume":"4","author":"JH Adair","year":"2010","unstructured":"Adair JH, Parette MP, Altinoglu EI, Kester M (2010) Nanoparticulate alternatives for drug delivery. ACS Nano 4:4967\u20134970","journal-title":"ACS Nano"},{"key":"9437_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"OC Farokhzad","year":"2009","unstructured":"Farokhzad OC, Langer R (2009) Impact of aanotechnology on drug delivery. ACS Nano 3:16\u201320","journal-title":"ACS Nano"},{"key":"9437_CR9","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.bmcl.2007.03.077","volume":"17","author":"E Turos","year":"2007","unstructured":"Turos E, Reddy GSK, Greenhalgh K, Ramaraju P, Abeylath SC, Jang S, Dickey S, Lim DV (2007a) Penicillin-bound polyacrylate nanoparticles: restoring the activity of \u00df-lactam antibiotics against MRSA. Bioorg Med Chem Lett 17:3468\u20133472. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2007.03.077","journal-title":"Bioorg Med Chem Lett"},{"key":"9437_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bmcl.2006.09.098","volume":"17","author":"E Turos","year":"2007","unstructured":"Turos E, Shim JY, Wang Y, Greenhalgh K, Reddy GSK, Dickey S, Lim DV (2007b) Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 17:53\u201356","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"9437_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0165-6147(96)01012-7","volume":"17","author":"S Hartsel","year":"1996","unstructured":"Hartsel S, Bolard J (1996) Amphotericin B: new life for an old drug. Trends Pharmacol Sci 17(12):445\u2013449","journal-title":"Trends Pharmacol Sci"},{"key":"9437_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0378-5173(02)00080-7","volume":"238","author":"R Cavalli","year":"2002","unstructured":"Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238:241\u2013245","journal-title":"Int J Pharm"},{"key":"9437_CR13","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1023\/A:1011925132473","volume":"15","author":"RM Fielding","year":"1998","unstructured":"Fielding RM, Lewis RO, Moon-McDermott L (1998) Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low clearance liposomes (MiKasome\u00ae). Pharm Res 15:1775\u20131781","journal-title":"Pharm Res"},{"key":"9437_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jbm.b.30994","volume":"86","author":"D Jain","year":"2008","unstructured":"Jain D, Banerjee R (2008) Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater 86:105\u2013112","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"9437_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1081\/LPR-200029887","volume":"14","author":"H Kim","year":"2004","unstructured":"Kim H, Jones MN (2004) The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J Liposome Res 14:123\u2013139","journal-title":"J Liposome Res"},{"key":"9437_CR16","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/AAC.37.11.2293","volume":"37","author":"M Magallanes","year":"1993","unstructured":"Magallanes M, Dijkstra J, Fierer J (1993) Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother 37:2293\u20132297","journal-title":"Antimicrob Agents Chemother"},{"key":"9437_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0006-2952(02)01346-1","volume":"64","author":"A Omri","year":"2002","unstructured":"Omri A, Suntres ZE, Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64:1407\u20131413","journal-title":"Biochem Pharmacol"},{"key":"9437_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","volume":"85","author":"R Pandey","year":"2005","unstructured":"Pandey R, Khuller GK (2005) Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85:227\u2013234","journal-title":"Tuberculosis"},{"key":"9437_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkg477","volume":"52","author":"R Pandey","year":"2003","unstructured":"Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B (2003) Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 52:981\u2013986","journal-title":"J Antimicrob Chemother"},{"key":"9437_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1211\/jpp.59.8.0002","volume":"59","author":"V Sanna","year":"2007","unstructured":"Sanna V, Gavini E, Cossu M, Rassu G, Giunchedi P (2007) Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol 59:1057\u20131064","journal-title":"J Pharm Pharmacol"},{"key":"9437_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2217\/fmb.11.27","volume":"6","author":"R Eckert","year":"2011","unstructured":"Eckert R (2011) Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol 6:635\u2013651","journal-title":"Future Microbiol"},{"key":"9437_CR22","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1016\/j.bbamem.2012.08.008","volume":"1818","author":"CA Carvalho","year":"2012","unstructured":"Carvalho CA, Olivares-Ortega C, Soto-Arriaza MA, Carmona-Ribeiro AM (2012) Interaction of gramicidin with DPPC\/DODAB bilayer fragments. Biochim Biophys Acta 1818:3064\u20133071","journal-title":"Biochim Biophys Acta"},{"key":"9437_CR23","first-page":"3183","volume":"9","author":"DAMT Ragioto","year":"2014","unstructured":"Ragioto DAMT, Carrasco LDM, Carmona-Ribeiro AM (2014) Novel gramicidin formulations in cationic lipid as broad-spectrum microbicidal agents. Int J Nanomedicine 9:3183\u20133192","journal-title":"Int J Nanomedicine"},{"key":"9437_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1473-3099(10)70220-6","volume":"11","author":"B Davies","year":"2011","unstructured":"Davies B, Cohen J (2011) Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect Dis 11:65\u201371","journal-title":"Lancet Infect Dis"},{"key":"9437_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","volume":"7","author":"H Shoji","year":"2003","unstructured":"Shoji H (2003) Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7:108\u2013114","journal-title":"Ther Apher Dial"},{"key":"9437_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/jac\/38.5.865","volume":"38","author":"M Cruciani","year":"1996","unstructured":"Cruciani M, Gatti G, Lazzarini L, Furlan G, Broccali G, Malena M, Franchini C, Concia E (1996) Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 38:865\u2013869","journal-title":"J Antimicrob Chemother"},{"key":"9437_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijantimicag.2010.10.011","volume":"37","author":"A Pumerantz","year":"2011","unstructured":"Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J, Betageri G (2011) Preparation of liposomal vancomycin and intracellular killing of methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 37:140\u2013144","journal-title":"Int J Antimicrob Agents"},{"key":"9437_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijantimicag.2010.01.015","volume":"35","author":"D Nicolosi","year":"2010","unstructured":"Nicolosi D, Scalia M, Nicolosi VM, Pignatello R (2010) Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. Int J Antimicrob Agents 35:553\u2013558","journal-title":"Int J Antimicrob Agents"},{"key":"9437_CR29","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1163\/092050611X570644","volume":"22","author":"T Ma","year":"2011","unstructured":"Ma T, Shang BC, Tang H, Zhou TH, Xu GL, Li HL, Chen QH, Xu YQ (2011) Nano-hydroxyapatite\/chitosan\/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed 22:1669\u20131681","journal-title":"J Biomater Sci Polym Ed"},{"key":"9437_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb.13.39","volume":"8","author":"T Velkov","year":"2013","unstructured":"Velkov T, Roberts KD, Nation RL, Thompson PE, Li J (2013) Pharmacology of polymyxins: new insights into an \u201cold\u201d class of antibiotics. Future Microbiol 8:711\u2013724","journal-title":"Future Microbiol"},{"key":"9437_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597\u2013602","journal-title":"Lancet Infect Dis"},{"key":"9437_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/jac\/dkq009","volume":"65","author":"A Kirby","year":"2010","unstructured":"Kirby A, Graham R, Williams NJ, Wootton M, Broughton CM, Alanazi M, Anson J, Neal TJ, Parry CM (2010) Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK. J Antimicrob Chemother 65:721\u2013724","journal-title":"J Antimicrob Chemother"},{"key":"9437_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijpharm.2006.06.005","volume":"324","author":"W Hachicha","year":"2006","unstructured":"Hachicha W, Kodjikian L, Fessi H (2006) Preparation of vancomycin microparticles: importance of preparation parameters. Int J Pharm 324:176\u2013184","journal-title":"Int J Pharm"},{"key":"9437_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-0033-1358747","volume":"64","author":"F Lotfipour","year":"2013","unstructured":"Lotfipour F, Abdollahi S, Jelvehgari M, Valizadeh H, Hassan M, Milani M (2013) Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against Enterococcus clinical isolates. Drug Res (Stuttg) 64:348\u2013352. \nhttps:\/\/doi.org\/10.1055\/s-0033-1358747","journal-title":"Drug Res (Stuttg)"},{"key":"9437_CR35","unstructured":"van Staden ADP (2011) Developing bone cement implants impregnated with bacteriocins for prevention of infections. MSc thesis, Stellenbosch University"},{"key":"9437_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2116\/analsci.26.755","volume":"26","author":"I Branowska","year":"2010","unstructured":"Branowska I, Wilczek A, Baranowski J (2010) Rapid UHPLC method for simultaneous determination of vancomycin, terbinafine, spironolactone, furosemide and their metabolites: application to human plasma and urine. Anal Sci 26:755\u2013759","journal-title":"Anal Sci"},{"key":"9437_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"JM Andrews","year":"2001","unstructured":"Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5\u201316","journal-title":"J Antimicrob Chemother"},{"key":"9437_CR38","first-page":"1","volume":"82","author":"RL Mccall","year":"2013","unstructured":"Mccall RL, Sirianni RW (2013) PLGA nanoparticles formed by single- or double-emulsion with vitamin E- TPGS. J Vis Exp 82:1\u20138","journal-title":"J Vis Exp"},{"key":"9437_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1081\/DDC-100102197","volume":"25","author":"JM Barichello","year":"1999","unstructured":"Barichello JM, Morishita M, Takayama K, Nagai T (1999) Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm 25:471\u2013476","journal-title":"Drug Dev Ind Pharm"},{"key":"9437_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"M Hans","year":"2002","unstructured":"Hans M, Lowman A (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6:319\u2013327","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"9437_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijpharm.2014.11.047","volume":"482","author":"M Garc\u00eda-D\u00edaz","year":"2015","unstructured":"Garc\u00eda-D\u00edaz M, Foged C, Nielsen HM (2015) Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids. Int J Pharm 482:84\u201391","journal-title":"Int J Pharm"},{"key":"9437_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11095-014-1467-3","volume":"32","author":"C Menale","year":"2015","unstructured":"Menale C, Piccolo MT, Favicchia I, Aruta MG, Baldi A, Nicolucci C, Barba V, Mita DG, Crispi S, Diano N (2015) Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells. Pharm Res 32:362\u2013374","journal-title":"Pharm Res"},{"key":"9437_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/pi.4822","volume":"64","author":"C Luo","year":"2015","unstructured":"Luo C, Okubo T, Nangrejo M, Edirisinghe M, Valizadeh H, Hassan M, Milani M (2015) Preparation of polymeric nanoparticles by novel electrospray nanoprecipitation. Polym Int 64:183\u2013187","journal-title":"Polym Int"},{"key":"9437_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00284-014-0635-3","volume":"69","author":"JJ Ahire","year":"2014","unstructured":"Ahire JJ, Neppalli R, Heunis TDJ, van Reenen AJ, Dicks LMT (2014) 2,3-Dihydroxybenzoic acid electrospun into poly (D, L-lactide) (PDLLA)\/poly (ethylene oxide) (PEO) nanofibers inhibited the growth of Gram-positive and Gram-negative bacteria. Curr Microbiol 69:587\u2013593","journal-title":"Curr Microbiol"},{"key":"9437_CR45","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377\u20131397","journal-title":"Polymers (Basel)"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-018-9437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12602-018-9437-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-018-9437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:35:21Z","timestamp":1600094121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12602-018-9437-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,30]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["9437"],"URL":"https:\/\/doi.org\/10.1007\/s12602-018-9437-4","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,30]]},"assertion":[{"value":"30 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}